ANDA 76477, held by Sun Pharm Inds Ltd. Atorvastatin Calcium.
As of Nov 16, 2026, ANDA 76477 (Atorvastatin Calcium), held by Sun Pharm Inds Ltd, was first approved by FDA on Nov 30, 2011, with 14 approved supplements and 0 published complete response letters.
Atorvastatin calcium tablets are indicated:
| Date | Submission | Status | Documents |
|---|---|---|---|
| Nov 30, 2011 | Original application | Approved |
| Atorvastatin CalciumEQ 10MG BASE · tablet;oral | Atorvastatin Calcium | Discontinued |
| Atorvastatin CalciumEQ 20MG BASE · tablet;oral | Atorvastatin Calcium | Discontinued |
| Atorvastatin CalciumEQ 40MG BASE · tablet;oral | Atorvastatin Calcium | Discontinued |
| Atorvastatin CalciumEQ 80MG BASE · tablet;oral | Atorvastatin Calcium | Discontinued |
| Dec 4, 2024 | Supplement 33Labeling · Standard review | Approved | None posted |
| Mar 15, 2023 | Supplement 31Labeling · Standard review | Approved | None posted |
| Jun 8, 2021 | Supplement 27Labeling · Standard review | Approved | None posted |
| Jun 8, 2021 | Supplement 26Labeling · Standard review | Approved | None posted |
| Jun 8, 2021 | Supplement 23Labeling · Standard review | Approved | None posted |
| Jun 8, 2021 | Supplement 17Labeling · Standard review | Approved | None posted |
| Jun 8, 2021 | Supplement 15Labeling · Standard review | Approved | None posted |
| Jun 8, 2021 | Supplement 12Labeling · Standard review | Approved | None posted |
| Jun 8, 2021 | Supplement 10Labeling · Standard review | Approved | None posted |
| Oct 6, 2015 | Supplement 7Labeling · Standard review | Approved | None posted |
| Sep 23, 2014 | Supplement 6Labeling · Standard review | Approved | None posted |
| Jan 27, 2013 | Supplement 5Labeling · Standard review | Approved | None posted |
| Apr 20, 2012 | Supplement 3Labeling | Approved | None posted |
| Jan 17, 2012 | Supplement 1Manufacturing | Approved | None posted |
| Nov 30, 2011 | Original application | Approved |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters